Your browser doesn't support javascript.
loading
Development of oral oncolytic nonadherence estimator (ORACLE): A pretreatment nonadherence risk assessment for oral oncolytics.
Signorelli, Jessie; Tran, Thuy; Sirek, Marie E; Díaz-Rohena, Yarelis; Taraba, Jodi L; Muluneh, Benyam; Basu, Nayanika; Lilly, Jennifer; Darling, Julianne.
Affiliation
  • Signorelli J; Pharmacy, Massachusetts General Hospital, Boston, MA, USA.
  • Tran T; Specialty Pharmacy Services, Atrium Health, Charlotte, NC, USA.
  • Sirek ME; Department of pharmacy, Billings Clinic, MT, USA.
  • Díaz-Rohena Y; NCODA University, National Community Oncology Dispensing Association, Cazenovia, NY, USA.
  • Taraba JL; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Muluneh B; Division of Pharmacotherapy and Experimental Therapeutics, University of Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA.
  • Basu N; Cancer Prevention and Control Program, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Lilly J; Department of Pharmacy, University of Virginia Breast Care Center, Charlottesville VA, USA.
  • Darling J; Department of Pharmacy, Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN, USA.
J Oncol Pharm Pract ; : 10781552231208442, 2023 Oct 30.
Article in En | MEDLINE | ID: mdl-37899586
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2023 Type: Article Affiliation country: United States